PM1 logo (Pramipexole Dihydrochloride 0.125 mg)
Pill with imprint PM1 logo is White, Round and has been identified as Pramipexole Dihydrochloride 0.125 mg. It is supplied by Watson Pharmaceuticals.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PM1 logo
Pramipexole Dihydrochloride
- Imprint
- PM1 logo
- Strength
- 0.125 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-3751
- Inactive Ingredients
-
mannitol,
corn starch,
silicon dioxide colloidal,
povidone k29/32,
magnesium stearate
Note: Inactive ingredients may vary.
More about pramipexole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 195 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
- Other brands
- Mirapex, Mirapex ER
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.